The percentages of IL-17+, IFN-γ+, or IL-17A+IFN-γ+ cells in Vδ2+ or total γδ T cells did not correlate with age at disease onset, disease duration, annualized relapse rate, EDSS score or MSSS in MS patients (data not shown). The gene discussed is IL17A; the disease is myeloid sarcoma.